These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29907443)

  • 1. APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe
    Romano G; Reggi S; Kutryb-Zajac B; Facoetti A; Chisci E; Pettinato M; Giuffrè MR; Vecchio F; Leoni S; De Giorgi M; Avezza F; Cadamuro M; Crippa L; Leone BE; Lavitrano M; Rivolta I; Barisani D; Smolenski RT; Giovannoni R
    Int J Cardiol; 2018 Nov; 271():233-239. PubMed ID: 29907443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-atherosclerotic effects of Polygonum aviculare L. ethanol extract in ApoE knock-out mice fed a Western diet mediated via the MAPK pathway.
    Haeng Park S; Sung YY; Jin Nho K; Kyoung Kim H
    J Ethnopharmacol; 2014 Feb; 151(3):1109-1115. PubMed ID: 24370878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Compendium of the Biological Effects of Apolipoprotein A-I
    Parolini C
    J Pharmacol Exp Ther; 2020 Jan; 372(1):54-62. PubMed ID: 31649050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I.
    Reimers GJ; Jackson CL; Rickards J; Chan PY; Cohn JS; Rye KA; Barter PJ; Rodgers KJ
    Cardiovasc Res; 2011 Jul; 91(1):37-44. PubMed ID: 21354994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice.
    Li X; Chyu KY; Faria Neto JR; Yano J; Nathwani N; Ferreira C; Dimayuga PC; Cercek B; Kaul S; Shah PK
    Circulation; 2004 Sep; 110(12):1701-5. PubMed ID: 15353488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
    Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4.
    Montecucco F; Braunersreuther V; Burger F; Lenglet S; Pelli G; Carbone F; Fraga-Silva R; Stergiopulos N; Monaco C; Mueller C; Pagano S; Dallegri F; Mach F; Vuilleumier N
    Thromb Haemost; 2015 Aug; 114(2):410-22. PubMed ID: 25879306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type).
    Ibanez B; Giannarelli C; Cimmino G; Santos-Gallego CG; Alique M; Pinero A; Vilahur G; Fuster V; Badimon L; Badimon JJ
    Atherosclerosis; 2012 Jan; 220(1):72-7. PubMed ID: 22030095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice.
    Pedersen TX; Bro S; Andersen MH; Etzerodt M; Jauhiainen M; Moestrup S; Nielsen LB
    Atherosclerosis; 2009 Feb; 202(2):372-81. PubMed ID: 18489910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipingshu capsule improves atherosclerosis associated with lipid regulation and inflammation inhibition in apolipoprotein E-deficient mice.
    Xu J; Ma C; Chen M; Rong S; Gao H; Xia Z; Huang F
    Lipids Health Dis; 2018 Jul; 17(1):182. PubMed ID: 30064511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food supplementation with rice bran enzymatic extract prevents vascular apoptosis and atherogenesis in ApoE-/- mice.
    Perez-Ternero C; Herrera MD; Laufs U; Alvarez de Sotomayor M; Werner C
    Eur J Nutr; 2017 Feb; 56(1):225-236. PubMed ID: 26476632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rice bran enzymatic extract reduces atherosclerotic plaque development and steatosis in high-fat fed ApoE-/- mice.
    Perez-Ternero C; Claro C; Parrado J; Herrera MD; Alvarez de Sotomayor M
    Nutrition; 2017 May; 37():22-29. PubMed ID: 28359358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization.
    Shah PK; Yano J; Reyes O; Chyu KY; Kaul S; Bisgaier CL; Drake S; Cercek B
    Circulation; 2001 Jun; 103(25):3047-50. PubMed ID: 11425766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of PKF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E-null mice.
    Terasaki M; Nagashima M; Watanabe T; Nohtomi K; Mori Y; Miyazaki A; Hirano T
    Metabolism; 2012 Jul; 61(7):974-7. PubMed ID: 22225957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic CGI-58 expression in macrophages alleviates the atherosclerotic lesion development in ApoE knockout mice.
    Xie P; Zeng X; Xiao J; Sun B; Yang D
    Biochim Biophys Acta; 2014 Dec; 1841(12):1683-90. PubMed ID: 25178844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice.
    Jahagirdar R; Zhang H; Azhar S; Tobin J; Attwell S; Yu R; Wu J; McLure KG; Hansen HC; Wagner GS; Young PR; Srivastava RA; Wong NC; Johansson J
    Atherosclerosis; 2014 Sep; 236(1):91-100. PubMed ID: 25016363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Efficacy of an ω-3-Fatty Acid-Containing 17-β Estradiol Nano-Delivery System against Experimental Atherosclerosis.
    Deshpande D; Kethireddy S; Janero DR; Amiji MM
    PLoS One; 2016; 11(2):e0147337. PubMed ID: 26840601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL.
    Qin W; Lu Y; Zhan C; Shen T; Dou L; Man Y; Wang S; Xiao C; Bian Y; Li J
    Cardiovasc Drugs Ther; 2012 Feb; 26(1):23-30. PubMed ID: 22038096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.